Pantomol (Pantoprazole)

Pantoprazole, the active ingredient in Pantomol, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is prescribed for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease, and Zollinger‑Ellison syndrome.

GNH USA supplies Pantomol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets with established logistics and regulatory support.

Pantoprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and acid reflux symptoms by reducing stomach acid. - Erosive esophagitis: promotes healing of inflamed esophageal tissue caused by acid exposure. - Peptic ulcer disease: supports ulcer healing and prevents recurrence by maintaining a higher gastric pH. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.

Pantoprazole may be associated with a range of adverse reactions, which are generally classified by frequency.

Common Side Effects: - Headache: mild to moderate pain in the head. - Diarrhea: loose stools occurring during treatment. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring emergency care. - Low magnesium levels: hypomagnesemia that may cause muscle cramps or cardiac arrhythmia.

When prescribing Pantoprazole, clinicians should consider several safety measures to minimize risk.

- Assess renal function: dose adjustment may be needed in severe impairment. - Monitor long‑term use: prolonged therapy can increase fracture risk and vitamin B12 deficiency. - Review concomitant medications: potential interactions may require dosage changes. - Use with caution in pregnancy: safety data are limited; benefits should outweigh potential risks. - Educate patients on infection signs: report persistent diarrhea or abdominal pain promptly. - Store at room temperature: keep in the original container, protect from moisture and heat.

Pantoprazole can affect the absorption or metabolism of several drugs; interactions are categorized by clinical significance.

Major Interactions (Avoid): - Atazanavir: reduced antiviral absorption leading to therapeutic failure. - Nelfinavir: decreased plasma concentrations compromising HIV treatment. - Rilpivirine: markedly lower exposure, risking loss of viral suppression.

Moderate Interactions (Monitor Closely): - Methotrexate: increased systemic exposure may cause toxicity. - Digoxin: higher serum levels may require monitoring. - Warfarin: altered anticoagulant effect; INR should be checked. - Iron salts: decreased iron absorption; separate dosing times.